Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2026-02-20 @ 8:08 PM
Study NCT ID:
NCT01846832
Status:
COMPLETED
Last Update Posted:
2016-09-21
First Post:
2013-05-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
Sponsor:
Janssen-Cilag International NV
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-01
First Submit QC Date:
None
Study First Post Date:
2013-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-20
Last Update Post Date:
2016-09-21
Last Update Post Date Type:
ESTIMATED